Close

Rosetta Genomics (ROSG) Announces Sale of PersonalizeDx Business to Pragmin Prognosis for $2.875M

September 8, 2017 8:37 AM EDT Send to a Friend
Rosetta Genomics Ltd. (NASDAQ: ROSG) announces that it has entered into a definitive agreement to sell all of its ownership ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login